Speaker illustration

Professor Lale Tokgozoglu

Hacettepe University, Ankara (Türkiye)

Member of:

European Society of Cardiology

Prof. Tokgözoğlu has served on the executive committee of the European Society of Atherosclerosis and is the immediate Past-President of the EAS. She is the Deputy Editor of the European Heart Journal.She has served as the president of the ‘Atherosclerosis and Vascular Biology Working Group of the European Society of Cardiology’ between 2008 and 2010. Prof. Tokgözoğlu has served on the board of the Prevention Association of the European Society of Cardiology between 2011-2016. She has been on the European Society of Cardiology Fellowship and Training Committee and the Education Committee. She was the President of the Turkish Society of Cardiology between 2014-2016 after serving on the executive committee for several years. Prof. Tokgözoğlu has been elected to the ‘Science Academy in Turkey’ in 2014. She is on the Editorial Board for European Heart Journal, Atherosclerosis, Anatolian Journal of Cardiology and Archives of the Turkish Society of Cardiology.

Great Debate: 'fire and forget' beats personalised lipid-lowering treatment

Event: ESC Congress 2024

Topic: Lipids

Session type: Great Debates

Thumbnail

Practical seminar for general clinicians

Event: ESC Congress 2024

Topic: Cardiovascular Disease in Primary Care

Session type: Practical Seminar

Thumbnail

HerHeart symposium: navigating LDL-C management for optimal cardiovascular health in women

Event: ESC Congress 2024

Topic: Cardiovascular Disease in Women

Session type: Satellite Symposium

Thumbnail

Nature Medicine: 2024 highlights in personalised cardiovascular medicine

Event: ESC Congress 2024

Topic: e-Cardiology/Digital Health

Session type: Official Joint Session

Thumbnail

Dyslipidaemia: novel diagnostics and therapy options

Event: ESC Congress 2024

Topic: Risk Factors and Prevention

Session type: Abstract Sessions

Thumbnail

Late-breaking science on pharmacology

Event: ESC Congress 2023

Topic: Pharmacology and Pharmacotherapy

Session type: Late-Breaking Science

Thumbnail

Women, dyslipidaemia and atherosclerosis: what is different?

Event: ESC Congress 2023

Topic: Cardiovascular Disease in Women

Session type: Symposium

Thumbnail

Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session type: Advances in Science

Thumbnail

Latest advancements in low-density lipoprotein cholesterol (LDL-C) lowering therapies and cardiovascular outcome trials

Event: ESC Congress 2023

Topic: Lipid-Lowering Agents

Session type: Satellite Symposium

Thumbnail

Essentials - beyond LDL: new targets and new treatments in lipid disorders

Event: ESC Preventive Cardiology 2023

Topic: Lipids

Session type: Special Session

Thumbnail